Efficacy and safety of pregabalin and duloxetine in painful diabetic neuropathy: a systematic review and meta-analysis
Pain Medicine · 2026
DOI: 10.1093/pm/pnaf155 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pain Medicine, 2026. Verfasst von Ahmed Mansour und 16 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Al-Azhar University, Cairo, Egypt. Hauptthemen laut MEDLINE: Pregabalin, Duloxetine Hydrochloride, Diabetic Neuropathies, Analgesics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Background and Objective Pregabalin (PGB) and duloxetine (DLX) are commonly used first-line medications in the clinical management of painful diabetic neuropathy (PDN), yet high-quality comparative evidence is limited. This meta-analysis evaluates the comparative efficacy and safety of PGB versus DLX, focusing on efficacy outcomes such as pain reduction and mental health, and safety outcomes including adverse events in PDN patients.
Method
We searched electronic databases for relevant studies assessing the efficacy and safety of PGB and DLX in PDN. The primary outcomes were the mean change of the Visual Analog Scale (VAS) and the improvement ratio for patients achieving ≥ 50% pain reduction. Secondary outcomes include the Numeric Rating Scale (NRS) for pain, the Short Form 12 Health Survey (SF-12), and related adverse events. A random-effects meta-analysis was performed to evaluate these outcomes.
Results
We analyzed 19 studies involving 4483 patients. PGB significantly reduced VAS scores at 24 weeks (MD = -0.38; 95% confidence interval [CI], -0.45 to -0.31; P < .0001) and decreased the mental component of SF-12 compared to DLX (MD = -3.36; 95% CI, -6.64 to -0.07; P = .05) and similar rates of achieving >50% pain reduction (risk ratio = 0.91; 95% CI, 0.81 to 1.03; P = .13). Regarding safety, PGB showed a lower incidence of several adverse events, including anorexia, decreased appetite, diarrhea, nausea, and vomiting. However, no significant differences in VAS scores were observed between PGB and DLX at 1 week, 2 weeks, 4 weeks, 6 weeks, 8 weeks, and 12 weeks, with similar results observed in NRS.
Conclusion
We found that PGB and DLX showed similar efficacy in relieving PDN. Ultimately, the 2 drugs’ similar effectiveness and different safety profiles highlight the importance of considering patient-specific factors when choosing the appropriate treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
- Medical Research Group of Egypt, Negida Academy, Arlington, MA, United States.
- Faculty of Medicine, Menoufia University, Cairo, Egypt.
- Faculty of Medicine, Kafr Elsheikh University, Kafr Elsheikh, Egypt.
- Departmment of Radiology, Yale University, New Haven, CT, United States.
- Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
ORCID-Profile: Ahmed Mansour, Ahmed Mostafa Amin, Ahmed Farid Gadelmawla, Ahmed Elbataa, Anas Mansour, Amr Elshahat, Abdallah Abbas
Zitieren
APA
Mansour, A., Amin, A. M., Farid Gadelmawla, A., Elbataa, A., Mansour, A., Elnady, M. I., Husain, M. A., Saad, O. A., Elshahat, A., Abbas, A., Elshahat, A., Mahmoud, Y., Abdelsatar, S. M., Elnaggar, M. Y., Fayk, A. E., Elbanna, A. F., & Abd-Elsayed, A. (2026). Efficacy and safety of pregabalin and duloxetine in painful diabetic neuropathy: a systematic review and meta-analysis. Pain Medicine. https://doi.org/10.1093/pm/pnaf155
Vancouver
Mansour A, Amin AM, Farid Gadelmawla A, Elbataa A, Mansour A, Elnady MI, et al. Efficacy and safety of pregabalin and duloxetine in painful diabetic neuropathy: a systematic review and meta-analysis. Pain Medicine. 2026. doi:10.1093/pm/pnaf155
BibTeX
@article{Mansour2026,
author = {Mansour, Ahmed and Amin, Ahmed Mostafa and Farid Gadelmawla, Ahmed and Elbataa, Ahmed and Mansour, Anas and Elnady, Mohamed Ismail and Husain, Muhammad Ashraf and Saad, Omar Abdulrahman and Elshahat, Amr and Abbas, Abdallah and Elshahat, Ahmed and Mahmoud, Youssef and Abdelsatar, Sohaila Mansour and Elnaggar, Mohamed Yasser and Fayk, Ayman E and Elbanna, Abdullah Farahat and Abd-Elsayed, Alaa},
title = {Efficacy and safety of pregabalin and duloxetine in painful diabetic neuropathy: a systematic review and meta-analysis},
journal = {Pain Medicine},
year = {2026},
doi = {10.1093/pm/pnaf155}
}
EUVIMED